THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Drug makers court small firms in push to fill thinning pipelines

By Christopher Rowland
Globe Staff / March 29, 2005

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

In an environment where big drug companies are furiously courting biotechnology companies for licensing deals, Ron Cohen is a hot date. (Full article: 897 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass